Coming Soon!!!

This netcast explores the rapidly changing world of biotech, with a penchant towards getting a better understanding of who we are and where we are going. The living world will soon be a true substrate for engineering. Our world will change, and so will we. 
We bring a first hand account from the scientists that are moving us into this new technological era: the era of biotech. 

Produced by Microbe.TV

 Artwork above by :




This form does not yet contain any fields.
    « FiB Episode 026: Senator Harrison Schmitt, The Last Man to Walk on the Moon | Main | FiB Episode 025: From the Human Genome Project to Space Exploration with Dr. George Church (Part I) »

    New Mighty Mouse in Town

    Here is another great example of metabolic engineering. We covered this area with Dr. Ron Evans in episode 22, who produced the first example of metabolic engineering or 'mighty mouse'. It looks like the there are other important enzymes that can be targeted as well to drive supermetabolism. Here is a movie of the supermouse produced in Richard W. Hanson's laboratory at Case Western Reserve University in Cleveland:

    Mighty Mouse

    The PEPCK-C enzyme now presents itself as a new pharmacological target. One could imagine in a relatively short time, having a PEPCK-C activator that could greatly improve metabolism.

    Original paper

    References (3)

    References allow you to track sources for this article, as well as articles that were written in response to this article.
    • Response
      The goals of educated or literate people are always high as compared to the people who are uneducated or literate. Because educated or literate people know that they can achieve their goals.
    • Response
    • Response
      Response: solitaire online
      This is the cards game which is free for solitaire users because this solitaire free online games makes people play with focus and online

    Reader Comments (4)


    Have you thought about having David Cheresh as a guest on the show? He visited us at the University of Chicago last week and had a lot to say about the intersection between academia and industry, especially in San Diego. He also does a lot of seminal work in angiogenesis and, increasingly, signaling.


    November 18, 2007 | Unregistered CommenterBen

    Would you mind sending me an email at

    I have a few questions for you.
    Thanks for the great suggestion.


    November 18, 2007 | Unregistered CommenterMarc Pelletier
    November 20, 2007 | Unregistered CommenterAnonymous

    I promise we'll get there!

    November 21, 2007 | Unregistered CommenterMarc Pelletier

    PostPost a New Comment

    Enter your information below to add a new comment.

    My response is on my own website »
    Author Email (optional):
    Author URL (optional):
    Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>